Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication

R. Borg, J. Nerup, D.M. Nathan, J. Kuenen, H. Zheng, D. Schoenfeld, R.J. Heine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Abstract

    Glycated haemoglobin (HbA 1c ) is widely used to determine levels of chronic glycaemia, to judge the adequacy of diabetes treatment and to adjust therapy. HbA 1c results are expressed as the percentage of HbA that is glycated. Day-to-day management is guided by self-monitoring of capillary glucose concentrations in mmol/l. The ADAG study determined the relationship between HbA 1c and average glucose concentration (AG) and concluded that for most patients with diabetes, HbA 1c can - with reasonable precision - be expressed as an estimated AG in the same units as self-monitoring
    Udgivelsesdato: 2009/11/2
    OriginalsprogEngelsk
    TidsskriftUgeskrift for læger
    Vol/bind171
    Udgave nummer45
    Sider (fra-til)3262-3265
    Antal sider3
    ISSN0041-5782
    StatusUdgivet - 2009

    Bibliografisk note

    DA - 20091113IS - 1603-6824 (Electronic)IS - 1603-6824 (Linking)LA - danPT - English AbstractPT - Journal ArticlePT - Multicenter StudyPT - Research Support, Non-U.S. Gov'tPT - Research Support, U.S. Gov't, Non-P.H.SRN - 0 (Blood Glucose)RN - 0 (Hemoglobin A, Glycosylated)SB - IM

    Citationsformater